iotaMotion Announces Issuance of U.S. Patent for Robotic-Assisted Cochlear Implantation Technology

The announcement comes on the heels of recent NIH grant awards leveraging the core technology platform of the iotaSOFT® Insertion System: The announcement comes on the heels of recent NIH grant awards leveraging the core technology platform of the iotaSOFT® Insertion System: "We are proud to see our industry-leading efforts recognized through this patent. Alongside recent grant-funded initiatives, this milestone reinforces the role our technology plays in both clinical practice and advancing...
Comunicato Precedente

next
Comunicato Successivo

next

The announcement comes on the heels of recent NIH grant awards leveraging the core technology platform of the iotaSOFT® Insertion System:

"We are proud to see our industry-leading efforts recognized through this patent. Alongside recent grant-funded initiatives, this milestone reinforces the role our technology plays in both clinical practice and advancing research to shape the future of cochlear implantation," said Costa Nikou, Chief Technology Officer at iotaMotion.

iotaMotion continues to advance the field of cochlear implantation through partnerships with academic and industry collaborators. Looking ahead, cochlear implantation is expected to integrate robotic assistance with enabling technology such as navigation and electrocochleography.

With hundreds of successful insertions with the iotaSOFT Insertion System completed at more than 25 centers across the United States, iotaMotion will continue to expand commercially, while innovating on its product roadmap.

About iotaMotion

iotaMotion, Inc. is a medical technology company based in St. Paul, MN, dedicated to advancing cochlear implant surgery beyond human capability through robotic-assisted solutions. Its flagship technology, the iotaSOFT® Insertion System, is designed to provide a slow and consistent electrode array insertion that is designed to preserve delicate intracochlear structures. The system is commercially available in the United States and under clinical investigation in other global markets.

For more information, visit www.iotamotion.com or contact Wade Colburn, Vice President of Marketing and Clinical, at [email protected].

Logo - https://mma.prnewswire.com/media/545464/iotaMotion_Inc___Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/iotamotion-announces-issuance-of-us-patent-for-robotic-assisted-cochlear-implantation-technology-302476906.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;